Search
Spotlight
ACTRIMS Forum 2021
ACTRIMS Forum 2021
Clinical Focus
View More
Dementia/Alzheimer
Epilepsy
Headache/Migraine
Movement Disorders
Multiple Sclerosis
Neuromuscular
Sleep Medicine
Stroke
Dementia/Alzheimer
Epilepsy
Headache/Migraine
Movement Disorders
Multiple Sclerosis
Neuromuscular
Sleep Medicine
Stroke
Video Series
Cure Connections
Insights
News Network
Peer Exchange
Cure Connections
Insights
News Network
Peer Exchange
News
Media
All Videos
Medical World News
Podcasts
Weekly Recap
All Videos
Medical World News
Podcasts
Weekly Recap
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
CME/CE
Partners
Resources
Fellows' Corner
Interactive Tools
Live Events
Neurology Resources
Publication
Resident Education
Virtual Events
Fellows' Corner
Interactive Tools
Live Events
Neurology Resources
Publication
Resident Education
Virtual Events
Subscribe
Search
Spotlight
ACTRIMS Forum 2021
Clinical Focus
See All >
Dementia/Alzheimer
Epilepsy
Headache/Migraine
Movement Disorders
Multiple Sclerosis
Neuromuscular
Sleep Medicine
Stroke
Video Series
Cure Connections
Insights
News Network
Peer Exchange
Insights
All Topics
Apply
Expert Perspectives: Advances in the Management of Acute Migraine
EP. 1:
Acute Migraine Management: Overview and Unmet Needs
EP. 2:
Goals of and Recommended Approach for Acute Treatment
EP. 3:
Acute Migraine Treatment: Pain Freedom and Guidelines
EP. 4:
Therapy Assessment: Pain Relief & Onset Monitorization
EP. 5:
The Importance of Patient Communication
EP. 6:
Recent Approvals for Acute Migraine
EP. 7:
The Significance of 5-HT1F Agonist Approval
EP. 8:
5-HT1F Agonist Toxicity Profile and Role in Paradigm
EP. 9:
CGRP Receptor Agonists: Safety and Efficacy
EP. 10:
The Role of Developing Agents in Acute Migraine Paradigm
Advances in the Management of Dravet Syndrome
EP. 1:
Overview of Dravet Syndrome
EP. 2:
Importance of Early Diagnosis of Dravet Syndrome
EP. 3:
Treatment Options for Dravet Syndrome
EP. 4:
Approval of Cannabidiol and Fenfluramine for Dravet
EP. 5:
Choosing Cannabidiol or Fenfluramine for Dravet
EP. 6:
Future Outlook for Dravet Syndrome
Case-Based Insights: Expert Perspectives on the Treatment of Epilepsy
EP. 1:
A 55-Year-Old Woman With Epilepsy
EP. 2:
Epilepsy Prevalence and Therapy Resistance
EP. 3:
Seizure Classification and Goals of Therapy
EP. 4:
Antiepileptic Therapy Half-Life, Dosing & Black Box Warning
EP. 5:
Antiepileptic Therapy Adverse Effects and Nonadherence
EP. 6:
How Treatment Efficacy Is Determined
EP. 7:
A Treatment Option for Uncontrolled Partial-Onset Seizures
EP. 8:
Real-World Practice: Perampanel for Partial-Onset Seizures
EP. 9:
Epilepsy Case Presentation and Diagnostic Process
EP. 10:
The Classification of Epilepsy and Seizures
EP. 11:
Anticonvulsants to Treat Epilepsy and Alternatives
EP. 12:
How Epilepsy Treatment Efficacy Is Determined
EP. 13:
Addressing Nonadherence to Therapy
EP. 14:
Treating Patients Who Are Unresponsive to Therapy
The Changing Treatment Landscape for Acute Migraine
EP. 1:
Burden of Migraine
EP. 2:
Acute Migraine Treatment Goals
EP. 3:
Advances in the Treatment of Acute Migraine
EP. 4:
Rimegepant Treatment for Acute Migraine
EP. 5:
Gepants for Acute Migraine: Safety & Efficacy Data
EP. 6:
Gepants for Acute Migraine: Patient Management
EP. 7:
Real-World Experience With Gepants for Acute Migraine
EP. 8:
Acute Migraine Treatment: What’s Next?
EP. 9:
Treating Acute Migraine in the Community Setting
EP. 10:
Treatment Goals for Acute Migraine
EP. 11:
Acute Migraine Treatment Goals
EP. 12:
Patient Selection for Acute Migraine Therapy
EP. 13:
Rimegepant: Treatment for Acute Migraine
EP. 14:
Ubrogepant: Treatment for Acute Migraine
EP. 15:
Therapies in Development for Acute Migraine
Optimal Management of OFF Episodes in Parkinson's Disease
EP. 1:
Overview of OFF Episodes in Parkinson’s Disease
EP. 2:
Apomorphine Subcutaneous Injection: Historical Perspective for Off-Episodes in Parkinson’s Disease
EP. 3:
Apomorphine Subcutaneous Injection: Efficacy and Administration for Off-Episodes in Parkinson Disease
EP. 4:
Apomorphine Subcutaneous Injection: Patient Selection for Off-Episodes in Parkinson Disease
EP. 5:
Apomorphine Subcutaneous Injection: Circle of Care Program for Off-Episodes in Parkinson Disease
EP. 6:
Recent Approval of Sublingual Apomorphine for Off-Episodes in Parkinson Disease
EP. 7:
Continuous Subcutaneous Apomorphine Infusion in Development for OFF Episodes in Parkinson’s Disease
EP. 8:
Levodopa Inhalation Powder for OFF Episodes in Parkinson’s Disease
EP. 9:
Recently Approved Oral Therapies for OFF Episodes in Parkinson’s Disease
EP. 10:
Device-Assisted and Surgical Options for Advanced Motor Fluctuations in Parkinson’s Disease
EP. 11:
Treating OFF Episodes in Parkinson’s Disease During COVID-19
Updates in Treatment of Adult Spinal Muscular Atrophy
EP. 1:
Overview of Spinal Muscular Atrophy
EP. 2:
Spectrum of SMA Phenotypes at Presentation
EP. 3:
Genetic Testing in SMA
EP. 4:
Considerations When Diagnosing SMA
EP. 5:
Assessing Motor Function in Later-Onset SMA
EP. 6:
Multidisciplinary Management of SMA
EP. 7:
Nusinersen Treatment for SMA
EP. 8:
The ENDEAR and CHERISH Trials in SMA
EP. 9:
Nusinersen in Adults With 5q SMA
EP. 10:
Real-World Experience Treating SMA With Nusinersen
EP. 11:
Risdiplam Under Study to Treat SMA
EP. 12:
Drugs in Development and Next Steps
EP. 13:
Treating SMA in the Community
Next >>